The Shingles vaccine is designed to protect against herpes zoster, a painful rash that can arise from the reactivation of the varicella-zoster virus, which causes chickenpox. The vaccine is recommended for adults aged 50 and over, as the risk of developing shingles and its complications increases with age. There are two main types of shingles vaccines: Zostavax, a live attenuated vaccine, and Shingrix, a recombinant vaccine that has been shown to be more effective. Vaccination can help reduce the likelihood of shingles, decrease pain severity, and lower the risk of postherpetic neuralgia, a common complication of the disease.
Age: 50 years +
Doses: Two Doses
The Shingles vaccine is designed to protect against herpes zoster, a painful rash that can arise from the reactivation of the varicella-zoster virus, which causes chickenpox. The vaccine is recommended for adults aged 50 and over, as the risk of developing shingles and its complications increases with age. There are two main types of shingles vaccines: Zostavax, a live attenuated vaccine, and Shingrix, a recombinant vaccine that has been shown to be more effective. Vaccination can help reduce the likelihood of shingles, decrease pain severity, and lower the risk of postherpetic neuralgia, a common complication of the disease.
Age: 50 years +
Doses: Two Doses
